DGX vs FMS
Quest Diagnostics Inc. and Fresenius Medical Care AG, side by side — 7 fiscal years reported in USD, drawn from SEC filings.
Most recent reported year
| Metric | DGX | FMS |
|---|---|---|
| Revenue | $11.0B | $14.6B |
| Net income | $992.0M | $1.1B |
| Gross margin | 33.2% | 32.4% |
| Net margin | 9.5% | 8.6% |
| Return on equity | 14.2% | 12.2% |
| Diluted EPS | $8.75 | $3.65 |
| Dividend / share | · | · |
| Payout ratio | 35.6% | 26.7% |
| Free cash flow | $1.4B | $1.3B |
| Equity | $7.2B | $9.2B |
| Net debt / equity | 0.73× | 0.78× |
| Current ratio | 1.04× | 1.77× |
| Revenue CAGR 5y | 3.2% | 6.6% |
| Profit CAGR 5y | −7.1% | 6.3% |
FMS bills 1.3× the revenue of DGX, and DGX keeps more of each dollar of revenue as profit (9.5% against 8.6%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
7 years side by side
| Fiscal year | DGX | FMS |
|---|---|---|
| FY2013 | $7.1B | $14.6B |
| FY2012 | $7.4B | $13.8B |
| FY2011 | $7.4B | $12.6B |
| FY2010 | $7.3B | $11.8B |
| FY2009 | $7.5B | $11.2B |
| FY2008 | $7.2B | $10.6B |
| FY2007 | $6.7B | $9.7B |
Bottom line
| Fiscal year | DGX | FMS |
|---|---|---|
| FY2013 | $849.0M | $1.1B |
| FY2012 | $556.0M | $1.2B |
| FY2011 | $471.0M | $1.1B |
| FY2010 | $720.9M | $978.5M |
| FY2009 | $729.1M | $891.1M |
| FY2008 | $581.5M | $817.6M |
| FY2007 | $339.9M | $717.1M |
7 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2013 | −$7,463,727,000 | FMS |
| FY2012 | −$6,417,282,000 | FMS |
| FY2011 | −$5,178,515,000 | FMS |
| FY2010 | −$4,584,074,000 | FMS |
| FY2009 | −$3,792,234,000 | FMS |
| FY2008 | −$3,362,876,000 | FMS |
| FY2007 | −$3,015,407,000 | FMS |
FMS has reported the higher revenue in every one of these 7 fiscal years. The gap has widened since the earliest year compared.
7 of 19 comparable fiscal years — a year missing data on either side is not counted.
7 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2013 | +3.8 pp | DGX |
| FY2012 | −1.6 pp | FMS |
| FY2011 | −2.5 pp | FMS |
| FY2010 | +1.4 pp | DGX |
| FY2009 | +1.7 pp | DGX |
| FY2008 | +0.4 pp | DGX |
| FY2007 | −2.3 pp | FMS |
The higher net margin has changed hands between DGX and FMS over this period.
7 of 19 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
DGX's net margin has been more volatile than FMS's over the 7 comparable fiscal years — 2.2 percentage points of standard deviation against 0.6.
7 of 19 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in net margin changed hands between DGX and FMS over these 7 fiscal years — DGX led in 4 and FMS in 3.
7 of 19 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
DGX's return on equity has been more volatile than FMS's over the 7 comparable fiscal years — 3.6 percentage points of standard deviation against 0.7.
7 of 19 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in return on equity changed hands between DGX and FMS over these 7 fiscal years — DGX led in 5 and FMS in 2.
7 of 19 comparable fiscal years — a year missing data on either side is not counted.